Abstract
The unbridled use of antimicrobial drugs over the last decades contributed to the global dissemination of drug-resistant pathogens and increasing rates of life-threatening infections for which limited therapeutic options are available. Currently, the search for safe, fast, and effective therapeutic strategies to combat infectious diseases is a worldwide demand. Antimicrobial photodynamic therapy (APDT) rises as a promising therapeutic approach against a wide range of pathogenic microorganisms. APDT combines light, a photosensitizing drug (PS), and oxygen to kill microorganisms by oxidative stress. Since the APDT field involves branches of biology and physics, the strengthening of interdisciplinary collaborations under the aegis of biophysics is welcome. Given this scenario, Brazil is one of the global leaders in the production of APDT science. In this review, we provide detailed reports of APDT studies published by the Laboratory of Optical Therapy (IPEN-CNEN), Group of Biomedical Nanotechnology (UFPE), and collaborators over the last 10 years. We present an integrated perspective of APDT from basic research to clinical practice and highlight its promising use, encouraging its adoption as an effective and safe technology to tackle important pathogens. We cover the use of methylene blue (MB) or Zn(II) porphyrins as PSs to kill bacteria, fungi, parasites, and pathogenic algae in laboratory assays. We describe the impact of MB-APDT in Dentistry and Veterinary Medicine to treat different infectious diseases. We also point out future directions combining APDT and nanotechnology. We hope this review motivates further APDT studies providing intuitive, vivid, and insightful information for the readers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alvarenga LH, Prates RA, Yoshimura TM et al (2015) Aggregatibacter actinomycetemcomitans biofilm can be inactivated by methylene blue-mediated photodynamic therapy. Photodiagnosis Photodyn Ther 12:131–135. https://doi.org/10.1016/j.pdpdt.2014.10.002
Alvarenga LH, Gomes AC, Carribeiro P et al (2019) Parameters for antimicrobial photodynamic therapy on periodontal pocket—randomized clinical trial. Photodiagnosis Photodyn Ther 27:132–136. https://doi.org/10.1016/j.pdpdt.2019.05.035
Andrade CG, Figueiredo RCBQ, Ribeiro KRC et al (2018) Photodynamic effect of zinc porphyrin on the promastigote and amastigote forms of Leishmania braziliensis. Photochem Photobiol Sci 17:482–490. https://doi.org/10.1039/C7PP00458C
Aureliano DP, Lindoso JAL, de Castro Soares SR et al (2018) Cell death mechanisms in Leishmania amazonensis triggered by methylene blue-mediated antiparasitic photodynamic therapy. Photodiagnosis Photodyn Ther 23:1–8. https://doi.org/10.1016/j.pdpdt.2018.05.005
Cabral FV, Sabino CP, Dimmer JA et al (2019) Preclinical investigation of methylene blue-mediated antimicrobial photodynamic therapy on Leishmania parasites using real-time bioluminescence. Photochem Photobiol 96(3):604–610. https://doi.org/10.1111/php.13188
Cabral FV, Lian C, Persheyev S et al (2021a) Organic light-emitting diodes as an innovative approach for treating cutaneous leishmaniasis. Adv Mater Technol 6:2100395. https://doi.org/10.1002/admt.202100395
Cabral FV, Sellera FP, Ribeiro MS (2021b) Methylene blue-mediated antimicrobial photodynamic therapy for canine dermatophytosis caused by Microsporum canis: a successful case report with 6 months follow-up. Photodiagnosis Photodyn Ther 36:102602. https://doi.org/10.1016/j.pdpdt.2021.102602
Cabral FV, Sellera FP, Ribeiro MS (2022) Feline sporotrichosis successfully treated with methylene blue-mediated antimicrobial photodynamic therapy and low doses of itraconazole. Photodiagnosis Photodyn Ther 40:103154. https://doi.org/10.1016/j.pdpdt.2022.103154
Cowen LE (2008) The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype. Nat Rev Microbiol 6(3):187–198
Daniell MD, Hill JS (1991) A history of photodynamic therapy. ANZ J Surg 61:340–348. https://doi.org/10.1111/j.1445-2197.1991.tb00230.x
de Senna AM, Vieira MMF, Machado-de-Sena RM et al (2018) Photodynamic inactivation of Candida ssp. on denture stomatitis. A clinical trial involving palatal mucosa and prosthesis disinfection. Photodiagnosis Photodyn Ther 22:212–216. https://doi.org/10.1016/j.pdpdt.2018.04.008
dos Anjos C, Sellera FP, Ribeiro MS et al (2020) Antimicrobial blue light and photodynamic therapy inhibit clinically relevant β-lactamases with extended-spectrum (ESBL) and carbapenemase activity. Photodiagnosis Photodyn Ther 32:102086. https://doi.org/10.1016/j.pdpdt.2020.102086
Engel A (2020) Fostering antibiotic development through impact funding. ACS Infect Dis 6:1311–1312. https://doi.org/10.1021/acsinfecdis.0c00069
Farooq S, da Silva Correia TT, Yoshimura TM et al (2019) Methylene blue-mediated photoinactivation of Staphylococcus aureus assisted by gold nanoshells. IFMBE Proceedings 70(2):841–845
Finsen NR (1901) Phototherapy. Edward Arnold, London, p 115
Fong W-P, Yeung H-Y, Lo P-C, Ng DKP (2017) Photodynamic therapy. In: Handbook of photonics for biomedical engineering. Springer, Netherlands, Dordrecht, pp 657–681
Grego KF, de Carvalho MP, Cunha MP, Knöbl T, Pogliani FC, Catão-Dias JL, Sant'Anna SS, Ribeiro MS, Sellera FP (2017) Antimicrobial photodynamic therapy for infectious stomatitis in snakes: clinical views and microbiological findings. Photodiagnosis Photodyn Ther 20:196–200. https://doi.org/10.1016/j.pdpdt.2017.10.004
Kato IT, Prates RA, Sabino CP et al (2013) Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity. Antimicrob Agents Chemother 57:445–451. https://doi.org/10.1128/AAC.01451-12
Madusanka RK, Silva H, Karunaweera ND (2022) Treatment of cutaneous leishmaniasis and insights into species-specific responses: a narrative review. Infect Dis Ther 11:695–711. https://doi.org/10.1007/s40121-022-00602-2
Nadimpalli M, Delarocque-Astagneau E, Love DC et al (2018) Combating global antibiotic resistance: emerging one health concerns in lower-and middle-income countries. Clin Infect Dis 66:963–969. https://doi.org/10.1093/cid/cix879
Nascimento CL, Ribeiro MS, Sellera FP et al (2015) Comparative study between photodynamic and antibiotic therapies for treatment of footpad dermatitis (bumblefoot) in Magellanic penguins (Spheniscus magellanicus). Photodiagnosis Photodyn Ther 12:36–44. https://doi.org/10.1016/j.pdpdt.2014.12.012
Prates RA, Fuchs BB, Mizuno K et al (2013) Effect of virulence factors on the photodynamic inactivation of Cryptococcus neoformans. PLoS One 8:e54387. https://doi.org/10.1371/journal.pone.0054387
Revie NM, Iyer KR, Robbins N, Cowen LE (2018) Antifungal drug resistance: evolution, mechanisms and impact. Curr Opin Microbiol 45:70–76
Ribeiro MS, de Melo LSA, Farooq S et al (2018) Photodynamic inactivation assisted by localized surface plasmon resonance of silver nanoparticles: In vitro evaluation on Escherichia coli and Streptococcus mutans. Photodiagnosis Photodyn Ther 22:191–196. https://doi.org/10.1016/j.pdpdt.2018.04.007
Rodrigues CH, Araújo EAG, Almeida RP et al (2021) Silver nanoprisms as plasmonic enhancers applied in the photodynamic inactivation of Staphylococcus aureus isolated from bubaline mastitis. Photodiagnosis Photodyn Ther 34:102315. https://doi.org/10.1016/j.pdpdt.2021.102315
Sabino CP, Wainwright M, dos Anjos C et al (2019) Inactivation kinetics and lethal dose analysis of antimicrobial blue light and photodynamic therapy. Photodiagnosis Photodyn Ther 28:186–191. https://doi.org/10.1016/j.pdpdt.2019.08.022
Sabino CP, Wainwright M, Ribeiro MS et al (2020) Global priority multidrug-resistant pathogens do not resist photodynamic therapy. J Photochem Photobiol B Biol 208:111893. https://doi.org/10.1016/j.jphotobiol.2020.111893
Sabino CP, Ribeiro MS, Wainwright M et al (2023) The biochemical mechanisms of antimicrobial photodynamic therapy. Photochem Photobiol 99:742–750. https://doi.org/10.1111/php.13685
Scwingel AR, Barcessat ARP, Núñez SC, Ribeiro MS (2012) Antimicrobial photodynamic therapy in the treatment of oral candidiasis in HIV-infected patients. Photomed Laser Surg 30:429–432. https://doi.org/10.1089/pho.2012.3225
Sellera FP, Sabino CP, Ribeiro MS et al (2014) Photodynamic therapy for pododermatitis in penguins. Zoo Biol 33:353–356. https://doi.org/10.1002/zoo.21135
Sellera F, Barbosa B, Gargano R et al (2015) Cutaneous streptococcal abscess treated by photodynamic therapy. African J Tradit Complement Altern Med 12:65. https://doi.org/10.4314/ajtcam.v12i2.12
Sellera FP, Gargano RG, Della LAMMP et al (2016a) Antimicrobial photodynamic therapy for caseous lymphadenitis abscesses in sheep: report of ten cases. Photodiagnosis Photodyn Ther 13:120–122. https://doi.org/10.1016/j.pdpdt.2015.12.006
Sellera FP, Sabino CP, Ribeiro MS et al (2016b) In vitro photoinactivation of bovine mastitis related pathogens. Photodiagnosis Photodyn Ther 13:276–281. https://doi.org/10.1016/j.pdpdt.2015.08.007
Sellera FP, Gargano RG, dos Anjos C et al (2018) Methylene blue-mediated antimicrobial photodynamic therapy: a novel strategy for digital dermatitis-associated sole ulcer in a cow – A case report. Photodiagnosis Photodyn Ther 24:121–122. https://doi.org/10.1016/j.pdpdt.2018.09.004
Sellera FP, Fernandes MR, Sabino CP et al (2019) Effective treatment and decolonization of a dog infected with carbapenemase (VIM-2)-producing Pseudomonas aeruginosa using probiotic and photodynamic therapies. Vet Dermatol 30:170–e52. https://doi.org/10.1111/vde.12714
Sellera FP, Barbosa BS, Gargano RG et al (2021) Methylene blue-mediated antimicrobial photodynamic therapy can be a novel non-antibiotic platform for bovine digital dermatitis. Photodiagnosis Photodyn Ther 34:102274. https://doi.org/10.1016/j.pdpdt.2021.102274
Simpkin VL, Renwick MJ, Kelly R, Mossialos E (2017) Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps. J Antibiot (Tokyo) 70:1087–1096. https://doi.org/10.1038/ja.2017.124
Souza THS, Andrade CG, Cabral FV et al (2021a) Efficient photodynamic inactivation of Leishmania parasites mediated by lipophilic water-soluble Zn(II) porphyrin ZnTnHex-2-PyP4+. Biochim Biophys Acta - Gen Subj 1865:129897. https://doi.org/10.1016/j.bbagen.2021.129897
Souza THS, Sarmento-Neto JF, Souza SO et al (2021b) Advances on antimicrobial photodynamic inactivation mediated by Zn(II) porphyrins. J Photochem Photobiol C Photochem Rev 49:100454. https://doi.org/10.1016/j.jphotochemrev.2021.100454
Souza SO, Raposo BL, Sarmento-Neto JF et al (2022) Photoinactivation of yeast and biofilm communities of Candida albicans mediated by ZnTnHex-2-PyP4+ porphyrin. J Fungi 8:556. https://doi.org/10.3390/jof8060556
Toledo VH, Yoshimura TM, Pereira ST et al (2020) Methylene blue-covered superparamagnetic iron oxide nanoparticles combined with red light as a novel platform to fight non-local bacterial infections: a proof of concept study against Escherichia coli. J Photochem Photobiol B Biol 209:111956. https://doi.org/10.1016/j.jphotobiol.2020.111956
Valandro P, Massuda MB, Rusch E et al (2021) Antimicrobial photodynamic therapy can be an effective adjuvant for surgical wound healing in cattle. Photodiagnosis Photodyn Ther 33:102168. https://doi.org/10.1016/j.pdpdt.2020.102168
Viana O, Ribeiro M, Rodas A et al (2015) Comparative study on the efficiency of the photodynamic inactivation of Candida albicans using CdTe quantum dots, Zn(II) porphyrin and their conjugates as photosensitizers. Molecules 20:8893–8912. https://doi.org/10.3390/molecules20058893
Funding
The studies here reported were funded by Brazilian agencies FAPESP, FACEPE, CNPq, CAPES, and CNEN.
Author information
Authors and Affiliations
Contributions
All authors equally contributed to this manuscript. FVC, THSS, FPS, AF, and MSR were responsible for conceptualization, writing, and revising the review.
Corresponding author
Ethics declarations
Ethical approval
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed in the studies here reported. Besides, all procedures performed in studies involving human participants were following the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Consent to participate
Not applicable.
Consent for publication
Elsevier granted permission to reproduce Fig. 1 (license number 5518491193627).
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cabral, F.V., dos Santos Souza, T.H., Sellera, F.P. et al. Strengthening collaborations at the Biology-Physics interface: trends in antimicrobial photodynamic therapy. Biophys Rev 15, 685–697 (2023). https://doi.org/10.1007/s12551-023-01066-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12551-023-01066-5